Pictet Asset Management Holding Sa Travere Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 762,908 shares of TVTX stock, worth $13.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
762,908
Previous 977,954
21.99%
Holding current value
$13.8 Million
Previous $8.04 Million
32.78%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TVTX
# of Institutions
194Shares Held
84.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$138 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$125 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$84.7 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$78.5 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.16B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...